$4.84
0.00%
Nasdaq, Thu, Dec 12 2024
ISIN
US30223G1022
Symbol
EXAI
Sector
Industry

Key metrics

Market capitalization $632.93m
Enterprise Value $330.45m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 15.22
P/S ratio (TTM) P/S ratio 29.15
P/B ratio (TTM) P/B ratio 1.85
Revenue growth (TTM) Revenue growth -27.63%
Revenue (TTM) Revenue $21.71m
EBIT (operating result TTM) EBIT $-221.68m
Free Cash Flow (TTM) Free Cash Flow $-137.80m
Cash position $327.39m
EPS (TTM) EPS $-1.51
P/E forward negative
P/S forward 12.36
EV/Sales forward 6.45
Short interest 4.30%
Show more

Is Exscientia a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.

Exscientia Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast Exscientia:

1x Hold
100%

Analyst Opinions

1 Analyst has issued a forecast Exscientia:

Hold
100%

Financial data from Exscientia

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
22 22
28% 28%
100%
- Direct Costs 60 60
9% 9%
276%
-38 -38
53% 53%
-176%
- Selling and Administrative Expenses 37 37
52% 52%
169%
- Research and Development Expense 123 123
22% 22%
568%
-198 -198
4% 4%
-913%
- Depreciation and Amortization 24 24
38% 38%
108%
EBIT (Operating Income) EBIT -222 -222
1% 1%
-1,021%
Net Profit -191 -191
9% 9%
-881%

In millions USD.

Don't miss a Thing! We will send you all news about Exscientia directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Exscientia Stock News

Neutral
Business Wire
2 months ago
OXFORD, England--(BUSINESS WIRE)--Exscientia plc (Nasdaq: EXAI) today announced the advancement of two additional discovery programmes within its collaboration with Sanofi, with Exscientia receiving an aggregate of $15 million in milestone payments. Both lead compounds have met the product profile requirements, set by both Exscientia and Sanofi, to enable a transition to the lead optimisation p...
Neutral
Business Wire
3 months ago
OXFORD, England--(BUSINESS WIRE)--Exscientia plc (Nasdaq: EXAI) today announced three abstracts to be presented at the 36th EORTC-NCI-AACR (ENA) Symposium 2024 from October 23-25, in Barcelona, Spain. “As our precision-designed LSD1 and MALT1 inhibitors continue to progress towards the clinic, we are excited to share new preclinical data from both programmes,” said David Hallett, Ph.D., interim...
Neutral
Business Wire
4 months ago
SAN MATEO, Calif.--(BUSINESS WIRE)--Brilliant, the designer and manufacturer of innovative smart home controls and home automation systems shares its acquisition by Almeida Strategic Investments, led by brothers Evan and Michael Almeida, in partnership with David Blum, owner of Cullinan Holdings. The private investment fuels the next generation of innovation for Brilliant's award-winning smart ...
More Exscientia News

Company Profile

Exscientia Plc engages in the application of artificial intelligence (AI) and machine learning (ML) to the discovery and design of therapeutic compounds. The company was founded by Andrew L. Hopkins in 2012 and is headquartered in Oxford, the United Kingdom.

Head office United Kingdom
CEO David Hallett
Employees 483
Founded 2012
Website www.exscientia.ai

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today